Date 1997-10-29

CURRICULUM VITAE

Name: Hernqvist, Per Håkan Erik
Born: 1950-01-09
Address: Alfhöjdsgatan 6, 431 38 Mölndal
Telephone: 031-160683 mobile 0709-670009
Mail:
Profile and qualities:

I have worked in the pharmaceutical business for 39 years, first within marketing and the last 30
years within clinical research. In this area I have conducted all moments within clinical trials, from
protocol development to report and publication. I have also been responsible author of an expert
report and a study summary in an application for a new indication. I have been monitoring studies
for 17 years and in parallel been heading a clinical research department with the responsibility for
all phase II-IV studies within the Gastrointestinal Area (Losec and Nexium) in Sweden for
AstraZeneca during 1983-2003. Year 2003 AstraZencea changed to a more generic, non
therapeutic area managed, organization and my job became more focused on line management
and coaching of coworkers (18 persons during 2009).
After leaving AstraZeneca in 2010 I have had several various assignments through my own
consultant agency, among others at Mölnlycke Health Care, Quintiles and Abigo Medical.
My strength is to see complex issues from a practical point of view, simplifying work while
maintaining quality standards according to ICH or SOPs.
I am a diplomatic person, having the ability to communicate difficult matters in a positive way, and
also having the ability to encourage and motivate other people to develop and do more than is
expected from them.
Employment:
Full clinical trial services provider through own consultant agency 2010- Dep Clinical Operations: Clinical Operations Manager 2006-2010 Dep Global Clinical Trials: Director 2004-2006 Dep Clinical Research Gastrointestinal: Director 1999-2003 Medical department: Associate Director 1985-1999 Medical department: Clinical research scientist 1983-85 Marketing department: Sales manager 1979-83 Marketing department: Sales representative 1976-77 Marketing department: Sales representative 1974-76 Spångbergsgymnasiet, Filipstad: Supply teacher 1974
Education:
Lund University: Bachelor of Science 1973; Chemistry & Biology Olympiaskolan, Helsingborg: Upper secondary school; 3 years natural sciences; Higher certificate 1969
Military Service:

Artillery: Quartermaster; Sergeant, 1969, 1970-71 (in total 15 months)

Postgraduate education:

Limnology 10p 1973
Nature Conservation 10p 1973
RUFI education for representatives in pharmaceutical industry 1974
Medical statistics 10p 1989
Various courses:

Apotekarsocieteten: Site audits, 2006 (2 days)
Dale Carnegie: Communication and Leadership, 2005 (10 weeks 1 day/week)
Management i Lund: MiL International Partnership, 2000-2001 (5 weeks + project work)
Dynargie: People Management, 1998-99 (3+2+2+2 days)
UGL: Development of Group and Leader, 1997 (One week)
ASTRA: Data Editing and Source Data Validation 1996 (3 days)
IFL: Marketing 1983 (3 weeks + project work)
Professional societies:

Apotekarsocieteten; Föreningen för klinisk läkemedelsprövning
Language skills.

English: Very good
German: Good
IT knowledge:

Good knowledge of Microsoft Office
Have within AstraZeneca worked with several internal IT systems and in connection with the
reorganisation 2009-10 led a work stream structuring e-Room and Intranet for the new AZ
Nordic organisation.
System owner of IMPACT in Sweden (AstraZeneca´s Clinical Trials Monitoring System) 2003-
2010

Publications:
Dahlgren S, Domellöf L, Hradsky M et al. The effects of omeprazole and cimetidine on duodenal ulcer healing and the relief of symptoms. Aliment Pharmacol Ther 1988;2 483-92 Lind T, Haglund U, and Hernqvist H. Omeprazole or ranitidine for two or four weeks in duodenal ulcer patients: effect on healing, symptoms, and ulcer recurrance during intermittent short term treatment. Gut 1989;30:A 1488 (Abstract) Kager L, Lindberg G, Nilsson L H et al. The effect of omeprazole and ranitidine on ulcer healing, relief of symptoms, and incidence of adverse events in the treament of duodenal ulcer patients. Hepatogastroenterology 1991;38:4 287-90 Dimenäs E, Glise H, Hallerbäck B, Hernqvist H, Svedlund J, Wiklund I. Quality of Life in Patients with Upper Gastrointestinal Symptoms. An Improved Evaluation of Treatment Regimens? Scand J Gastroenterol 1993;28:681-687 Dimenäs E, Glise H, Hallerbäck B, Hernqvist H, Svedlund J, Wiklund I. Well-being and
gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal
ulcer. Scand J of Gastroenterol 1995;30:1046-1052
Lind T, Havelund T, Carlsson R, Glise H, Hernqvist H, Junghard O et al. The effect of
omeprazole 20 mg and 10 mg daily on heartburn in patients with endoscopy negative reflux
disease. Gastroenterolgy 1995;103: A 192
Johnsson F, Weywadt L, Solhaug J-H, Hernqvist H, Bengtsson L. One week omeprazole
treatment in the diagnosis of gastroesophageal reflux. Gut 1996:39 (suppl 1) T 155
Lind T, Havelund T, Carlsson R, Glise H, Hernqvist H, Junghard O et al. Heartburn without
esophagitis: efficacy of omeprazole therapy and features determining therapeutic response.
Scand J Gastroenterol 1997;32:974-979
Johnsson F, Weywadt L, Solhaug J-H, Hernqvist H, Bengtsson L. One week omeprazole
treatment in the diagnosis of gastroesophageal reflux. Scand J Gastroenterol 1998:34:15-20

Family:

Wife: Kerstin
Daughter: Elisabeth (born 88)
Sons: Fredrik (born 90) and Joakim (born 95)
Hobbies:
Music (plays the clarinet in a jazz band)
Sailing
Down-hill skiing
Photography
Bird Watching

References:
Sven Karlsson, Facilities Director Mölndal, Sweden Business Services,
Astra Zeneca AB, Mölndal, Phone +46 (0)31 7763660, Mobile +46 761 256 761
Carin Fellenius, Site Management & Monitoring Director Western EU Södertälje,
Phone +46 (0)8 55323053
Peter Asplund, Director Clinical Operations Sweden and Norway, Managing Director,
Quintiles AB, Uppsala, Phone +46 18 4311114, Mobile + 46 733 319 114

Source: http://hctconsulting.se/CV.pdf